Lab X.0
Addressing Quality and Compliance Challenges
in Laboratory Operations in the COVID-19 All-Digital Era

An FDAnews FREE Webinar • Sponsored by Xybion
Thursday, Feb. 11, 2021 • 11:00 a.m. - 12:00 p.m. EST

Is COVID-19 testing the boundaries and limitations of your quality and compliance processes and systems? The pandemic has affected all laboratory operations in regulated industries from test and clinical trial sites, to ordering physicians, to diagnostic labs, to the healthcare system. As laboratories struggle to meet the demand of test collection sites with full regulatory quality and compliance, they must find ways to expedite their core business processes at the same time. Likewise, the new normal of replacing outdated systems with the latest digital technologies has become the unwritten requirement for success in the Life Sciences Industry.

Leading laboratories and life sciences companies are experiencing how digital transformation is an opportunity to overcome regulatory challenges and modernize their business processes with an advanced digital LIMS unified with Quality, Compliance, predictive risk mitigation, Instrument Calibration, Training Records, document management, and Sample Management.

Regulated businesses can now leverage compliance, quality, and digital lab information systems holistically and remotely from the cloud.

To meet the requirements of today’s challenges, all regulated businesses must:

  • Enabling tracking and tracing from collection site to healthcare providers and regulatory bodies.
  • Create a new paradigm for the post-COVID-19 world of holistic digital quality and compliance management.
  • Always be ready for e-Audit, e-Sourcing and e-Inspections.
  • Bring results to markets at rapid speeds with full regulatory compliance in the digital workplace.

Please join our webinar to learn how you can benefit from the latest advancements in Quality and Compliance with Unified LIMS.

Who Will Benefit

  • Quality affairs
  • Regulatory affairs
  • Information technology

Sign Up for FREE Below

Meet Your Presenters


Pradip K. Banerjee, Ph.D.

Chairman of the Board and Chief Executive Officer

Pradip K. Banerjee, Ph.D. is Xybion’s Chairman of the Board and Chief Executive Officer. He is the founding Managing Partner (retired) of Accenture’s research and development line of business. He is an entrepreneurial senior executive with more than 30 years of in-depth experience in the global life sciences, healthcare and services industries in operations, strategic management, business development, investments and new venture creations. Previously, he held several research and development management positions at Abbott, Glaxo-Smith Kline and also served as president and CEO of the Science Center in Philadelphia.


Dhanashri Gudi, Ph.D.

Laboratory Management Specialist and Subject Matter Expert

Dhanashri Gudi, Ph.D. is Xybion’s Laboratory Management Specialist and Subject Matter Expert. At Xybion she oversees laboratory software implementation along with product design and development. Dr. Gudi holds over 15 years of experience in drug discovery and development with a strong focus on drug metabolism, drug transporters, pharmacokinetics and clinical pharmacology. Previously she held R&D positions at Abbvie and Jubilant Biosys. She is also an entrepreneur, setting up a training academy in collaboration with Certara. Dr. Gudi is an alumnus of IU School of Medicine & West Virginia University.